Black licorice compound shows promise against inflammatory bowel disease

Researchers developed a stem cell-based model of the human intestine to discover new IBD treatments and identified glycyrrhizin as a promising anti-inflammatory candidate. The compound reduced intestinal damage and cell death in lab-grown tissue and mice. This breakthrough may transform how new IBD treatments are discovered.